JAMA Commentary Urges Realistic View of New CAR T-Cell Cancer Therapy – AJMC.com Managed Markets Network
pharmaphorum |
JAMA Commentary Urges Realistic View of New CAR T-Cell Cancer Therapy
AJMC.com Managed Markets Network The 3 oncologists from Memorial Sloan Kettering Cancer Center acknowledged the “impressive science” behind the therapy marketed as Kymriah, which involves genetically modifying each patient's chimeric antigen receptor (CAR) T cells to target and kill … Premium price for Novartis' CAR–T sparks pushback from top PBM |
